Profiles

Postdoc Profile: Finding the Narrative Behind the Numbers

Dr. Shameka Poetry Thomas Documents Black Women’s Experiences With Race and Racism

Dr. Shameka Poetry Thomas

The numbers are clear: Black women are three to four times more likely to die from pregnancy-related causes than White women in the United States. However, the reasons why are less clear. By listening to patient’s stories, IRP postdoctoral fellow Shameka Thomas, Ph.D. hopes to pinpoint potential explanations for this racial health disparity. 

“We are losing mothers and children because we are simply not listening,” Dr. Thomas says.

Trained as a medical sociologist at the University of Miami, Dr. Thomas has devoted her career to documenting the lived experiences of patients of color, particularly women, who are perceived as Black. Dr. Thomas contextualizes patient’s narratives within a framework of ‘street race,’ which refers to how a person’s racial identity is perceived by others, regardless of their self-reported racial identity. Examining the influence of street race on women’s healthcare experiences, she explains, allows researchers to determine how health disparities are influenced by “how others see you.”

New Lasker Scholars Begin Breaking New Ground

Early-Career Scientists Power Through Pandemic to Launch Labs

NIH’s 2021 Lasker Clinical Research Scholars

NIH has long prided itself on its ability to accelerate the careers of the brightest young physicians and scientists in the country. One of these many efforts is the Lasker Clinical Research Scholars Program, which provides a select group of individuals relatively early in their scientific careers with the funding and institutional support to start their own labs at NIH. After five to seven years of independent research in the IRP, Lasker Scholars are given the option to apply for three years of funding for work outside of NIH or to remain as investigators at NIH.

While launching a lab in the midst of a global pandemic is no easy task, five Lasker Scholars have done just that over the past year. Their research on cancer, Parkinson’s disease, childhood blindness, and inflammatory conditions is now well underway and promises to eventually improve the lives of many patients. Keep reading to learn more about how NIH’s newest Lasker Scholars are changing the way we treat those illnesses.

IRP’s Carolina Barillas-Mury Elected to National Academy of Medicine

NIH Researcher Recognized for Important Insights Into Malaria Transmission

Dr. Carolina Barillas-Mury

In many parts of the world, the high-pitched buzz of a mosquito is a harbinger of more than an annoying itch — it’s a warning of possible malaria infection. Malaria, a disease spread by mosquitos that causes high fever and flu-like illness, is a serious risk for nearly half of the world’s population. According to the World Health Organization, there were 241 million cases of malaria and 627,000 deaths in 2020 alone. More than 95 percent of them occurred in Africa.

Efforts to combat malaria using measures like preventative treatments and environmental mitigation have helped to reduce infections and deaths over the past decade, but those improvements have recently plateaued, according to IRP Distinguished Investigator Carolina Barillas-Mury, M.D., Ph.D., section chief in the Laboratory of Malaria and Vector Research in the National Institute of Allergy and Infectious Diseases (NIAID).

Postdoc Profile: An Engineer Among Epidemiologists

Dr. Shuai Xie Brings a New Perspective to Research on Environmental Exposures

Dr. Shuai Xie

“Engineering is about solving problems,” says IRP postdoctoral fellow Shuai Xie, Ph.D., M.P.H.

Dr. Xie speaks from experience. One of the problems she was interested in solving during her graduate studies in chemical and environmental engineering was how to accurately measure the way airborne contaminants adhere to and release from indoor building materials. This is a particularly important problem to solve because those interactions can affect measurements of indoor air pollution, potentially rendering them inaccurate. Of course, Dr. Xie was not trying to solve this engineering problem for its own sake; accurately gauging contamination of indoor air is important for human health.

A Conversation with NIH Director Francis Collins

World-Renowned Geneticist Discusses His Experience Leading NIH

Dr. Francis Collins

Francis S. Collins, who is stepping down from his post as NIH Director by the end of the year, spoke recently with staff from The NIH Catalyst, the NIH Record, and the “I am Intramural” Blog. Read on for a few highlights from that conversation, or read the full interview originally published The NIH Catalyst.

On NIH’s efforts to improve diversity in the scientific workforce

“Diversity is a hugely important issue for our workforce, our grantee community, and our clinical-trials participation. Several years ago I put together a diversity working group of my advisory committee, and out of that came the creation of a new position, the Chief Officer for Scientific Workforce Diversity. The initial holder of that post was Dr. Hannah Valantine, and now Dr. Marie Bernard leads the office. In addition, we have made real strides in increasing diversity in our intramural program through the Distinguished Scholars Program.

IRP’s Gary Gibbons and Eliseo Pérez-Stable Receive Government Award for COVID-19 Response

Pair Leads Public Health Efforts Focused on Underserved Communities

Dr. Gary Gibbons (left) and Dr. Eliseo Pérez-Stable (right)

In the spring of 2020, as the U.S. government implemented public health measures to address the COVID-19 pandemic, it quickly became clear that people in Black, Latino, and American Indian communities were significantly more likely to be hospitalized or die from the new disease than White, non-Hispanic Americans. While the work many scientists did to understand the virus and devise vaccines, diagnostic tests, and treatments made the news regularly, efforts to study and address racial disparities in COVID-19’s impacts were equally important.

When called to lead efforts to shrink those gaps, Gary H. Gibbons, M.D., and Eliseo J. Pérez-Stable, M.D., rose to the challenge. The two IRP investigators, who respectively lead the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Minority Health and Health Disparities (NIMHD), helped direct two federal programs dedicated to providing underserved communities with information about, and access to, COVID-19 testing, clinical trials, and vaccines. In recognition of their life-saving work, Drs. Gibbons and Pérez-Stable have been awarded the COVID-19 Response Medal, a special honor bestowed this year as part of the Samuel J. Heyman Service to America Medals. Also known as the “Sammies,” these annual awards recognize and celebrate exceptional work by government employees

IRP’s Steven Rosenberg Receives HHS Secretary’s Award for Distinguished Service

Groundbreaking Immunotherapy Research Revolutionizes Cancer Treatment

Dr. Steven Rosenberg

Like many young boys, IRP senior investigator Steven A. Rosenberg, M.D., Ph.D., initially believed he would grow up to become a cowboy, a dream he shared with his older brother, Jerry. That plan changed after World War II ended and stories began coming out of Europe about members of his family who had perished in concentration camps.

“I just became so upset about the evil that people could perpetrate on one another,” he recalls. “Right then and there, I knew I wanted to do the opposite. I wanted to do things that would help people, and I developed almost a spiritual desire to become a doctor.”

He ultimately did become a doctor, and his pioneering research into how cancer interacts with the immune system has led to treatments that are reducing suffering for many people with cancer. In recognition of this groundbreaking work, Dr. Rosenberg was awarded the HHS Secretary’s Award for Distinguished Service in August 2021. The highest honor given by the US Department of Health and Human Services (HHS), the award celebrates excellence in leadership, ability, and service.

Postdoc Profile: COVID-19 Provides New Opportunities for Virus Science

Dr. Alberto D. López-Muñoz Pivots to New Research Focus Amidst Pandemic

Dr. Alberto D. López-Muñoz

Like all virologists, IRP postdoctoral fellow Alberto D. López-Muñoz, Ph.D., knew a global pandemic was sadly inevitable. No one could predict exactly when, but it was just a matter of time until a novel virus would make its way around the globe. Nevertheless, when the COVID-19 pandemic hit, caused by a virus called SARS-CoV-2, even Dr. López-Muñoz was surprised by how rapidly his career transformed as he switched gears study the novel contagion.

Changing the Face of the IRP

Marie A. Bernard Leads NIH Efforts to Recruit “Great Minds That Think Differently”

Dr. Marie A. Bernard

The summer of 2020 will likely be remembered as a turning point in America. The murder of George Floyd and the disproportionate effects of the COVID-19 pandemic on communities of color brought the simmering scourge of racism and race-related disparities to the center of public debate and convinced many Americans that something needs to be done.

The biomedical research enterprise has long dealt with its own inequities as well, including outright discrimination against people from certain groups. As a result, a top priority of the National Institutes of Health is to bring greater equity to the scientific and medical workforce and the patients and communities it serves. In her new role as NIH’s Chief Officer for Scientific Workforce Diversity (COSWD), Marie A. Bernard, M.D., has big plans to push the needle further towards reaching that goal.

Breakthrough Treatment Brings Hope to Children with Tumor Disorder

Brigitte Widemann Recognized for Pioneering Work on Debilitating Disease

Dr. Brigitte C. Widemann

Getting diagnosed with a serious illness as an adult can be devastating, so one can hardly imagine the impact of receiving such news as a child, particularly when the disease has no good treatments. Until recently, this was the case for many children with the potentially severe and frequently disfiguring condition neurofibromatosis type 1 (NF1). However, pioneering research led by IRP senior investigator Brigitte C. Widemann, M.D., led to the first-ever drug approved by the U.S. Food and Drug Administration (FDA) to treat the condition. For this groundbreaking work, Dr. Widemann, her IRP research team, and her collaborators outside NIH were named as finalists for the 2020 Samuel J. Heyman Service to America Medals, also known as the ‘Sammies,’ an award that honors exceptional work by government employees.